Phase I Dose Escalation Study of the Safety and Pharmacokinetics of ME-143 Single Agent for Refractory Solid Tumors
Clinical trial NCT01401868 · COMPLETED
Trial details
- NCT number
- NCT01401868
- Sponsor
- MEI Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2012-09-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.